BAY 77-1931 Long-term Extension From Phase II Study

Clinical trial NCT00769496 · COMPLETED

Trial details

NCT number: NCT00769496
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperphosphatemia

Start date: 2005-01-01
Primary completion: 2008-05-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.